Day: February 5, 2024

ING to propose Deloitte as new external auditor ING will propose to the 2024 Annual General Meeting of Shareholders to appoint Deloitte Accountants BV as its next external auditor for a term of four years starting on 1 January 2026. The AGM will take place on 22 April 2024. Under European and Dutch legislation, ING is required to change its auditor at regular intervals. The nomination of Deloitte is the result of a thorough tender process overseen by the Audit Committee of the Supervisory Board and in accordance with the ING Group Policy on Auditors Independence. The audit of the 2023, 2024 and 2025 annual accounts will still be performed by KPMG Accountants NV, who have been ING’s auditor since January 2016 and will have reached the legally set maximum duration of 10 years at the end of 2025. Note for editors For further information...

Saint-Herblain (France), February 5, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it sold the Priority Review Voucher (PRV) it received from the U.S. Food and Drug Administration (FDA) for $103 million (€95 million). The Company was awarded a tropical disease PRV in November 20231 following U.S. FDA approval of IXCHIQ®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. With this approval, IXCHIQ® became the world’s first licensed chikungunya vaccine available to address this unmet medical need. Valneva will invest proceeds from the sale of the PRV into its R&D projects, including the co-development of its Phase 3 vaccine...

OSLO, Norway (5 February 2024) – TGS, a global provider of energy data and intelligence, in a strategic collaboration with SLB, today announced the Engagement 5 Ocean Bottom Node (OBN) multi-client acquisition in the U.S. Gulf of Mexico. Commencing in Q1 2024, the initiation of the seventh program within the seismic joint venture involves the acquisition of 157 OCS blocks [3,650 square kilometers] through a long offset, sparse OBN survey. The expansion of data coverage in the eastern region of Green Canyon will adjoin with prior phases, establishing a continuous coverage area spanning over 23,000 square kilometers from the Mississippi Canyon in the east to Garden Banks in the west. The industry recently participated in the Gulf of Mexico Lease Sale 261, where blocks within the survey area attracted 16 winning bids and a total bid value...

 Fast Track designation is granted for UV1 in combination with ipilimumab and nivolumab for the treatment of patients with unresectable malignant pleural mesothelioma to improve overall survival The designation was granted by the U.S. Food and Drug Administration (FDA) based on results from the randomized Phase II clinical trial NIPU, which showed improved overall survival with UV1 vaccination as an add-on to ipilimumab and nivolumab immunotherapy UV1 as add-on therapy had previously received Orphan Drug designation for the treatment of mesothelioma and Fast Track designation for unresectable or metastatic melanomaOslo, February 5, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today announced that the U.S. Food and Drug Administration (FDA) had granted...

VANCOUVER, British Columbia, Feb. 04, 2024 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:CLB) (the “Company” or “Christina Lake Cannabis” or “CLC”), a leading producer of high quality extracts and sun grown cannabis, is pleased to announce the results of voting at its Annual General and Special Meeting of Shareholders (the “Meeting”) held on February 2, 2024. A total of 69,708,588 common shares were voted at the Meeting, representing 53.16% of the votes attached to all outstanding common shares of the Company. Shareholders voted in favour of all items of business presented at the Meeting, including the re-election of all director nominees as follows: Joel Dumaresq, Salvatore Milia, Nicco Dehaan, Mervin Boychuk, Gil Playford and James McMillan. Shareholders also approved the re-appointment...